secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cencora, Inc. (COR)
CIK:        0001140859
Form:       8-K
Filed at:   2025-05-07T23:59:59+00:00
Accession:  0001140859-25-000081
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cencora Q2 FY2025 revenue $75.5B (+10.3% YoY); adj. EPS $4.42 (+16.3%); raises FY guidance
--------------------------------------------------------------------------------

- Revenue $75.5B, +10.3% YoY; GAAP diluted EPS $3.68 vs $2.09 prior year.
- Adjusted diluted EPS $4.42, up 16.3% from $3.80; adjusted net income $863M.
- FY2025 adjusted diluted EPS guidance raised to $15.70-$15.95 from $15.30-$15.60.
- CEO Robert Mauch highlights strength of value proposition and pharmaceutical distribution.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1140859/000114085925000081/0001140859-25-000081-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1140859/000114085925000081/abc-20250507.htm
  HTML page:      https://secwatch.observer/filing/0001140859-25-000081

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer